INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,568,223 | -73.5% | 28,024 | -75.5% | 0.01% | -73.5% |
| Q2 2022 | $5,921,499 | -47.3% | 114,403 | -26.1% | 0.05% | -31.0% |
| Q1 2022 | $11,245,392 | +5.5% | 154,746 | +71.7% | 0.07% | +14.5% |
| Q4 2021 | $10,656,025 | -28.9% | 90,122 | -19.3% | 0.06% | -43.6% |
| Q3 2021 | $14,990,055 | -30.8% | 111,741 | -16.4% | 0.11% | -19.1% |
| Q2 2021 | $21,647,367 | +122.1% | 133,700 | +10.1% | 0.14% | +58.1% |
| Q1 2021 | $9,747,211 | +646.6% | 121,453 | +406.1% | 0.09% | +681.8% |
| Q4 2020 | $1,305,600 | +406.0% | 24,000 | +84.6% | 0.01% | +266.7% |
| Q3 2020 | $258,000 | -64.2% | 13,000 | -73.6% | 0.00% | -50.0% |
| Q4 2019 | $721,000 | – | 49,175 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |